Welcome to LookChem.com Sign In|Join Free

CAS

  • or
DL-Tyrosine is an amino acid that exists in two forms, D-tyrosine and L-tyrosine, which are mirror images of each other. It is a white powder and is a crucial component in the synthesis of proteins, neurotransmitters, and hormones in the body. DL-Tyrosine plays a significant role in various biological processes and has potential applications in different industries.

556-03-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 556-03-6 Structure
  • Basic information

    1. Product Name: DL-Tyrosine
    2. Synonyms: (R,S)-2-Amino-3-(4-hydroxy-phenyl)-propionicacid;DL-p-Tyrosine;3-(4-HYDROXYPHENYL)-DL-ALANINE;(+/-)-2-AMINO-3-(4-HYDROXYPHENYL)PROPIONIC ACID;2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONIC ACID;DL-TYROSINE;DL-3-(4-HYDROXYPHENYL)ALANINE;H-DL-TYR-OH
    3. CAS NO:556-03-6
    4. Molecular Formula: C9H11NO3
    5. Molecular Weight: 181.19
    6. EINECS: 209-113-1
    7. Product Categories: Tyrosine [Tyr, Y];alpha-Amino Acids;Amino Acids;Biochemistry;Amino Acids;Amino Acids and Derivatives
    8. Mol File: 556-03-6.mol
  • Chemical Properties

    1. Melting Point: 325 °C
    2. Boiling Point: 314.29°C (rough estimate)
    3. Flash Point: 186.74 °C
    4. Appearance: /Crystalline
    5. Density: 1.2375 (rough estimate)
    6. Refractive Index: 1.5270 (estimate)
    7. Storage Temp.: Store at RT.
    8. Solubility: Aqueous Acid (Slightly), Methanol (Slightly), Water (Slightly)
    9. PKA: pK1:2.18(+1);pK2:9.11(0);pK3:10.6(OH) (25°C)
    10. Water Solubility: Soluble in water.
    11. Stability: Stable. Incompatible with strong oxidizing agents.
    12. Merck: 14,9839
    13. BRN: 515881
    14. CAS DataBase Reference: DL-Tyrosine(CAS DataBase Reference)
    15. NIST Chemistry Reference: DL-Tyrosine(556-03-6)
    16. EPA Substance Registry System: DL-Tyrosine(556-03-6)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-36
    4. WGK Germany: 3
    5. RTECS:
    6. TSCA: Yes
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 556-03-6(Hazardous Substances Data)

556-03-6 Usage

Uses

Used in Pharmaceutical Industry:
DL-Tyrosine is used as a building block for the synthesis of various pharmaceutical compounds, including drugs that target the central nervous system and other physiological processes. Its incorporation into the diet can help in the study of protein synthesis and its effects on muscle protein in different physiological conditions.
Used in Nutritional Supplements:
DL-Tyrosine is used as a dietary supplement to support cognitive function, stress response, and overall well-being. It can be particularly beneficial for individuals undergoing high-stress situations or those who require enhanced mental performance.
Used in Research and Development:
DL-Tyrosine is used as a research tool in the study of protein synthesis, neurotransmitter function, and hormonal regulation. Its isotopic labeling allows for the tracking of protein incorporation and the investigation of its effects on muscle protein in various conditions, such as infection.
Used in Cosmetics Industry:
DL-Tyrosine can be used in the cosmetics industry for the development of skincare products that aim to improve skin health and appearance by supporting the synthesis of proteins and other essential molecules in the skin.

Check Digit Verification of cas no

The CAS Registry Mumber 556-03-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,5 and 6 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 556-03:
(5*5)+(4*5)+(3*6)+(2*0)+(1*3)=66
66 % 10 = 6
So 556-03-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)

556-03-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (T0549)  DL-Tyrosine  >98.0%(HPLC)(T)

  • 556-03-6

  • 5g

  • 190.00CNY

  • Detail
  • TCI America

  • (T0549)  DL-Tyrosine  >98.0%(HPLC)(T)

  • 556-03-6

  • 25g

  • 450.00CNY

  • Detail
  • Alfa Aesar

  • (A13740)  DL-Tyrosine, 98%   

  • 556-03-6

  • 10g

  • 260.0CNY

  • Detail
  • Alfa Aesar

  • (A13740)  DL-Tyrosine, 98%   

  • 556-03-6

  • 50g

  • 748.0CNY

  • Detail
  • Alfa Aesar

  • (A13740)  DL-Tyrosine, 98%   

  • 556-03-6

  • 250g

  • 3659.0CNY

  • Detail
  • Aldrich

  • (145726)  DL-Tyrosine  99%

  • 556-03-6

  • 145726-25G

  • 613.08CNY

  • Detail
  • Aldrich

  • (145726)  DL-Tyrosine  99%

  • 556-03-6

  • 145726-100G

  • 2,045.16CNY

  • Detail

556-03-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (.+-.)-Tyrosine

1.2 Other means of identification

Product number -
Other names DL-TYROSINE USP GRADE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:556-03-6 SDS

556-03-6Relevant articles and documents

Rational engineering ofAcinetobacter tandoiiglutamate dehydrogenase for asymmetric synthesis ofl-homoalanine through biocatalytic cascades

Diao, Shiqing,Jiang, Shuiqin,Liu, Yan,Sun, Yangyang,Wang, Hualei,Wang, Liuzhu,Wei, Dongzhi

, p. 4208 - 4215 (2021/06/30)

l-Homoalanine, a useful building block for the synthesis of several chiral drugs, is generally synthesized through biocascades using natural amino acids as cheap starting reactants. However, the addition of expensive external cofactors and the low efficiency of leucine dehydrogenases towards the intermediate 2-ketobutyric acid are two major challenges in industrial applications. Herein, a dual cofactor-dependent glutamate dehydrogenase fromAcinetobacter tandoii(AtGluDH) was identified to help make full use of the intracellular pool of cofactors when using whole-cell catalysis. Through reconstruction of the hydrophobic network between the enzyme and the terminal methyl group of the substrate 2-ketobutyric acid, the strict substrate specificity ofAtGluDH towards α-ketoglutarate was successfully changed, and the activity obtained by the most effective mutant (K76L/T180C) was 17.2 times higher than that of the wild-type protein. A three-enzyme co-expression system was successfully constructed in order to help release the mass transfer restriction. Using 1 Ml-threonine, which is close to the solubility limit, we obtained a 99.9% yield ofl-homoalanine in only 3.5 h without adding external coenzymes to the cascade, giving 99.9% ee and a 29.2 g L?1h?1space-time yield. Additionally, the activities of the engineeredAtGluDH towards some other hydrophobic amino acids were also improved to 1.1-11.2 fold. Therefore, the engineering design of some dual cofactor-dependent GluDHs could not only eliminate the low catalytic activity of unnatural substrates but also enhance the cofactor utilization efficiency of these enzymes in industrial applications.

Scope and limitations of reductive amination catalyzed by half-sandwich iridium complexes under mild reaction conditions

Nguyen, Dat P.,Sladek, Rudolph N.,Do, Loi H.

supporting information, (2020/07/15)

The conversion of aldehydes and ketones to 1° amines could be promoted by half-sandwich iridium complexes using ammonium formate as both the nitrogen and hydride source. To optimize this method for green chemical synthesis, we tested various carbonyl substrates in common polar solvents at physiological temperature (37 °C) and ambient pressure. We found that in methanol, excellent selectivity for the amine over alcohol/amide products could be achieved for a broad assortment of carbonyl-containing compounds. In aqueous media, selective reduction of carbonyls to 1° amines was achieved in the absence of acids. Unfortunately, at Ir catalyst concentrations of 1 mM in water, reductive amination efficiency dropped significantly, which suggest that this catalytic methodology might be not suitable for aqueous applications where very low catalyst concentration is required (e.g., inside living cells).

Biocascade Synthesis of L-Tyrosine Derivatives by Coupling a Thermophilic Tyrosine Phenol-Lyase and L-Lactate Oxidase

Jiang, Yiqi,Ju, Shuyun,Li, Guosi,Lian, Jiazhang,Lin, Jianping,Wu, Mianbin,Xue, Hailong,Yang, Lirong

supporting information, (2020/02/25)

A one-pot biocascade of two enzymatic steps catalyzed by an l-lactate oxidase and a tyrosine phenol-lyase has been successfully developed in the present study. The reaction provides an efficient method for the synthesis of l-tyrosine derivatives, which exhibits readily available starting materials and excellent yields. In the first step, an in situ generation of pyruvate from readily available bio-based l-lactate catalyzed by a highly active l-lactate oxidase from Aerococcus viridans (AvLOX) was developed (using oxygen as oxidant and catalase as hydrogen peroxide removing reagent). Pyruvate thus produced underwent C–C coupling with phenol derivatives as acceptor substrate using specially designed thermophilic tyrosine phenol-lyase mutants from Symbiobacterium toebii (TTPL). Overall, this cascade avoids the high cost and easy decomposition of pyruvate and offered an efficient and environmentally friendly procedure for l-tyrosine derivatives synthesis.

Direct Synthesis of Free α-Amino Acids by Telescoping Three-Step Process from 1,2-Diols

Inada, Haruki,Shibuya, Masatoshi,Yamamoto, Yoshihiko

supporting information, p. 709 - 713 (2019/01/25)

A practical telescoping three-step process for the syntheses of α-amino acids from the corresponding 1,2-diols has been developed. This process enables the direct synthesis of free α-amino acids without any protection/deprotection step. This method was also effective for the preparation of a 15N-labeled α-amino acid. 1,2-Diols bearing α,β-unsaturated ester moieties afforded bicyclic α-amino acids through intramolecular [3 + 2] cycloadditions. A preliminary study suggests that the resultant α-amino acids are resolvable by aminoacylases with almost complete selectivity.

Electrosynthesis of amino acids from biomass-derivable acids on titanium dioxide

Fukushima, Takashi,Yamauchi, Miho

supporting information, p. 14721 - 14724 (2019/12/24)

Seven amino acids were electrochemically synthesized from biomass-derivable α-keto acids and NH2OH with faradaic efficiencies (FEs) of 77-99% using an earth-Abundant TiO2 catalyst. Furthermore, we newly constructed a flow-Type electrochemical reactor, named a "polymer electrolyte amino acid electrosynthesis cell", and achieved continuous production of alanine with an FE of 77%.

Oxidative cyclization of N-methyl-dopa by a fungal flavoenzyme of the amine oxidase family

Lahham, Majd,Pavkov-Keller, Tea,Fuchs, Michael,Niederhauser, Johannes,Chalhoub, Gabriel,Daniel, Bastian,Kroutil, Wolfgang,Gruber, Karl,Macheroux, Peter

, p. 17021 - 17032 (2018/11/21)

Flavin-dependent enzymes catalyze many oxidations, including formation of ring structures in natural products. The gene cluster for biosynthesis of fumisoquins, secondary metabolites structurally related to isoquinolines, in the filamentous fungus Aspergillus fumigatus harbors a gene that encodes a flavoprotein of the amine oxidase family, termed fsqB (fumisoquin biosynthesis gene B). This enzyme catalyzes an oxidative ring closure reaction that leads to the formation of isoquinoline products. This reaction is reminiscent of the oxidative cyclization reported for berberine bridge enzyme and tetrahydrocannabinol synthase. Despite these similarities, amine oxidases and berberine bridge enzyme–like enzymes possess distinct structural properties, prompting us to investigate the structure–function relationships of FsqB. Here, we report the recombinant production and purification of FsqB, elucidation of its crystal structure, and kinetic analysis employing five putative substrates. The crystal structure at 2.6 ? resolution revealed that FsqB is a member of the amine oxidase family with a covalently bound FAD cofactor. N-methyl-dopa was the best substrate for FsqB and was completely converted to the cyclic isoquinoline product. The absence of the meta-hydroxyl group, as e.g. in L-Nmethyl-tyrosine, resulted in a 25-fold lower rate of reduction and the formation of the demethylated product L-tyrosine, instead of a cyclic product. Surprisingly, FsqB did not accept the D-stereoisomer of N-methyltyrosine, in contrast to N-methyl-dopa, for which both stereoisomers were oxidized with similar rates. On the basis of the crystal structure and docking calculations, we postulate a substrate-dependent population of distinct binding modes that rationalizes stereospecific oxidation in the FsqB active site.

Method for the production of high-level soluble human recombinant interferon alpha in e. coli and vectors useful for such a production

-

, (2009/01/20)

Method for the production of high-level soluble human recombinant interferon alpha protein (rhuIFNα) in E. coli and vectors useful for such a production. Said method comprises the steps of: (1) Transforming an E. coli selected in the group consisting of E. coli protease deficient host strains, and E. coli reductase deficient host strains, with a recombinant expression vector comprising the sequence encoding the glutathione-S-transferase (GST), a junction sequence including a recognition site for a specific protease and a sequence able to encode an interferon alpha (IFN alpha) protein under the control of an inducible promoter, said vector encoding a GST-IFN alpha fusion protein (2) Expressing said interferon alpha protein in conditions comprising the induction of the expression with 0.1 mM-0.5 mM IPTG and a growth temperature of 25° and/or 37°C, depending on said E. coli strain and (3) Isolating the expressed IFN alpha protein.

Growth Hormone Secretagogue Receptor 1A Ligands

-

, (2009/01/20)

The present invention relates to new growth hormone secretagogue receptor 1A (GHS-R 1A) ligands, and pharmaceutical compositions comprising any of the new GHS-R1 A ligands. The ligands are suitable for a wide range of applications, and thus the present invention also relates to use of the GHS-R1 A ligands according to the present invention in the manufacture of a medicament for the treatment of an individual in need thereof. In another aspect, the present invention relates to a method of treatment of an individual in need thereof, comprising administering to said individual one or more of the GHS-R1A ligands disclosed herein, such as e.g. for treatment of cancer cachexia.

Cell-proliferation inhibiting VPg proteins, fragments or analogs thereof and their applications

-

, (2009/01/24)

Use of VPg proteins, fragments or analogs thereof having the ability to bind an eukaryotic initiation factor eIF4E, for inhibiting cell-proliferation.

METHOD FOR SYNTHESIS OF KETO ACID OR AMINO ACID BY HYDRATION OF ACETHYLENE COMPOUND

-

Page/Page column 24, (2008/12/06)

An object of the present invention is to provide a method for synthesis of keto acids by hydration of an acetylene compound (acetylene-carboxylic acids) under mild conditions free from harmful mercury catalysts and a method for synthesis of amino acids from acetylene-carboxylic acids in a single container (one-pot or tandem synthesis). In one embodiment of the method according to the present invention for synthesis of keto acids, acetylene-carboxylic acids is hydrated in the presence of a metal salt represented by General Formula (1), where M1 represents an element in Group VIII, IX, or X of the periodic table, and X1, X2, or X3 ligand represents halogen, H2O, or a solvent molecule, and k represents a valence of a cation species, and Y represents an anion species, and L represents a valence of the anion species, and each of K and L independently represents 1 or 2, and k × m = L × n.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 556-03-6